Rockefeller Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $17.8M | Buy |
124,926
+1,138
| +0.9% | +$173K | 0.03% | 542 |
|
|
2026
Q2 | $19.4M | Buy |
123,788
+5,481
| +5% | +$822K | 0.03% | 495 |
|
|
2026
Q1 | $18.1M | Buy |
118,307
+10,102
| +9% | +$1.55M | 0.03% | 468 |
|
|
2025
Q4 | $14.9M | Buy |
108,205
+5,526
| +5% | +$724K | 0.03% | 518 |
|
|
2025
Q3 | $13.2M | Buy |
102,679
+4,936
| +5% | +$602K | 0.03% | 549 |
|
|
2025
Q2 | $11.8M | Sell |
97,743
-3,920
| -4% | -$442K | 0.03% | 564 |
|
|
2025
Q1 | $11.3M | Sell |
101,663
-6,139
| -6% | -$654K | 0.03% | 536 |
|
|
2024
Q4 | $10.5M | Buy |
107,802
+2,189
| +2% | +$233K | 0.03% | 544 |
|
|
2024
Q3 | $12.1M | Sell |
105,613
-4,910
| -4% | -$557K | 0.03% | 484 |
|
|
2024
Q2 | $11.8M | Sell |
110,523
-38,218
| -26% | -$3.84M | 0.03% | 460 |
|
|
2024
Q1 | $14.4M | Buy |
148,741
+46,960
| +46% | +$4.81M | 0.04% | 412 |
|
|
2023
Q4 | $10.3M | Sell |
101,781
-24,750
| -20% | -$2.39M | 0.03% | 450 |
|
|
2023
Q3 | $12.9M | Sell |
126,531
-70,296
| -36% | -$7.14M | 0.05% | 357 |
|
|
2023
Q2 | $19.8M | Buy |
196,827
+3,918
| +2% | +$392K | 0.08% | 269 |
|
|
2023
Q1 | $17.7M | Sell |
192,909
-20,676
| -10% | -$1.81M | 0.08% | 291 |
|
|
2022
Q4 | $19.4M | Sell |
213,585
-243
| -0.1% | -$20.5K | 0.1% | 236 |
|
|
2022
Q3 | $16.3M | Sell |
213,828
-525
| -0.2% | -$43.5K | 0.08% | 256 |
|
|
2022
Q2 | $18.1M | Buy |
214,353
+13,074
| +6% | +$1.15M | 0.1% | 221 |
|
|
2022
Q1 | $17.7M | Sell |
201,279
-22,266
| -10% | -$1.93M | 0.09% | 246 |
|
|
2021
Q4 | $19.6M | Buy |
223,545
+13,505
| +6% | +$1.12M | 0.09% | 224 |
|
|
2021
Q3 | $17.2M | Buy |
210,040
+9,174
| +5% | +$825K | 0.09% | 235 |
|
|
2021
Q2 | $18.3M | Buy |
200,866
+67,553
| +51% | +$6.02M | 0.1% | 218 |
|
|
2021
Q1 | $11.4M | Buy |
133,313
+29,186
| +28% | +$2.62M | 0.08% | 241 |
|
|
2020
Q4 | $9.8M | Sell |
104,127
-47,264
| -31% | -$4.13M | 0.07% | 228 |
|
|
2020
Q3 | $13.2M | Sell |
151,391
-740,514
| -83% | -$64.2M | 0.12% | 169 |
|
|
2020
Q2 | $77.9M | Sell |
891,905
-277,255
| -24% | -$23.9M | 0.82% | 22 |
|
|
2020
Q1 | $96.4M | Sell |
1,169,160
-70,193
| -6% | -$6.26M | 1.26% | 16 |
|
|
2019
Q4 | $117M | Sell |
1,239,353
-18,723
| -1% | -$1.68M | 1.46% | 13 |
|
|
2019
Q3 | $109M | Buy |
1,258,076
+9,133
| +0.7% | +$820K | 1.48% | 15 |
|
|
2019
Q2 | $114M | Sell |
1,248,943
-12,126
| -1% | -$1.03M | 1.59% | 15 |
|
|
2019
Q1 | $121M | Buy |
1,261,069
+9,640
| +0.8% | +$864K | 1.73% | 16 |
|
|
2018
Q4 | $107M | Buy |
1,251,429
+39,244
| +3% | +$3.41M | 1.88% | 16 |
|
|
2018
Q3 | $104M | Buy |
1,212,185
+222,141
| +22% | +$18.3M | 1.59% | 21 |
|
|
2018
Q2 | $74.8M | Sell |
990,044
-13,035
| -1% | -$1M | 1.22% | 28 |
|
|
2018
Q1 | $81.1M | Sell |
1,003,079
-3,243
| -0.3% | -$276K | 1.34% | 23 |
|
|
2017
Q4 | $84.5M | Sell |
1,006,322
-50,324
| -5% | -$4.24M | 1.33% | 27 |
|
|
2017
Q3 | $90.7M | Sell |
1,056,646
-4,041
| -0.4% | -$341K | 1.73% | 17 |
|
|
2017
Q2 | $88.5M | Sell |
1,060,687
-3,630
| -0.3% | -$287K | 1.76% | 19 |
|
|
2017
Q1 | $79M | Sell |
1,064,317
-8,577
| -0.8% | -$638K | 1.58% | 23 |
|
|
2016
Q4 | $78.2M | Sell |
1,072,894
-7,613
| -0.7% | -$551K | 1.59% | 24 |
|
|
2016
Q3 | $85.3M | Sell |
1,080,507
-65,564
| -6% | -$5.33M | 1.78% | 21 |
|
|
2016
Q2 | $94.6M | Sell |
1,146,071
-9,923
| -0.9% | -$765K | 1.89% | 19 |
|
|
2016
Q1 | $83.7M | Sell |
1,155,994
-4,922
| -0.4% | -$374K | 1.63% | 26 |
|
|
2015
Q4 | $100M | Sell |
1,160,916
-5,193
| -0.4% | -$460K | 1.94% | 13 |
|
|
2015
Q3 | $107M | Buy |
1,166,109
+21,449
| +2% | +$2.13M | 2.18% | 9 |
|
|
2015
Q2 | $113M | Buy |
1,144,660
+23,466
| +2% | +$2.4M | 2.33% | 8 |
|
|
2015
Q1 | $111M | Sell |
1,121,194
-16,795
| -1% | -$1.66M | 2.39% | 9 |
|
|
2014
Q4 | $105M | Sell |
1,137,989
-16,538
| -1% | -$1.53M | 2.31% | 11 |
|
|
2014
Q3 | $109M | Buy |
1,154,527
+57,682
| +5% | +$5.21M | 2.42% | 6 |
|
|
2014
Q2 | $99.3M | Buy |
1,096,845
+21,152
| +2% | +$1.86M | 2.23% | 7 |
|
|
2014
Q1 | $91.5M | Buy |
1,075,693
+36,352
| +3% | +$2.96M | 1.98% | 9 |
|
|
2013
Q4 | $83.5M | Buy |
1,039,341
+57,680
| +6% | +$4.47M | 1.81% | 9 |
|
|
2013
Q3 | $75.3M | Buy |
981,661
+23,126
| +2% | +$1.71M | 1.75% | 11 |
|
|
2013
Q2 | $67.8M | Hold |
958,535
| – | – | 1.62% | 14 |
|
Other funds holding NVS
Rockefeller Capital Management's NVS Position: Q3 2026 in Review
Rockefeller Capital Management increased its Novartis (NVS) stake by 0.92% in Q3 2026, buying an estimated $173K and bringing the position to 124,926 shares worth $17.8M. The position accounts for 0.03% of the portfolio, ranked #542.
Rockefeller Capital Management first reported a position in NVS in Q2 2013 and has held it in 54 quarters since. The position peaked at $121M in Q1 2019. 1,560 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Rockefeller Capital Management held 124,926 shares of Novartis worth $17.8M as of Q3 2026.
- Rockefeller Capital Management bought 1,138 Novartis shares in Q3 2026, an estimated $173K.
- Novartis made up 0.03% of Rockefeller Capital Management's portfolio in Q3 2026, its #542 holding.
- Rockefeller Capital Management first reported a position in Novartis in Q2 2013 and has held it in 54 quarters since.
- Rockefeller Capital Management's Novartis position peaked at $121M in Q1 2019.
- 1,560 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.